Related Experiment Video
Updated: Mar 18, 2026
Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
Cerebral Magnetic Resonance Imaging in Children With Prenatal Drug Exposure
Eivind Sirnes1,2, Irene B Elgen1,2, W K Chong3
11 Haukeland University Hospital, Bergen, Norway.
Insights
Cerebral MRI scans in children with prenatal drug exposure showed no distinct pathology patterns. Standard MRI analysis appears to have limited clinical value for assessing these children.
Area of Science:
- Pediatric Radiology
- Neuroimaging
- Developmental Neuroscience
Background:
- Prenatal exposure to substances like alcohol, opioids, and polysubstances can impact child development.
- Cerebral magnetic resonance imaging (MRI) is a key tool for evaluating brain structure and function.
- Assessing the neurobiological effects of prenatal drug exposure in children is crucial for clinical management.
Purpose of the Study:
- To evaluate the utility of cerebral MRI in identifying pathologies in children with documented prenatal drug exposure.
- To determine if specific MRI findings correlate with prenatal exposure to alcohol, opioids, or polysubstances.
- To assess the clinical value of standard cerebral MRI in the assessment of children exposed to drugs prenatally.
Main Methods:
- A hospital-based cohort study included children aged 10-14 years with and without prenatal drug exposure.
- Cerebral MRI scans were performed on 34 exposed children and 40 matched controls.
- An experienced pediatric neuroradiologist, blinded to exposure status, scored MRI scans for pathology.
Main Results:
- Overall detectable MRI pathology was observed in 35% of exposed children and 33% of controls (OR = 1.08, 95% CI = 0.36-3.25).
- Simple visual analysis of cerebral MRI scans did not reveal any specific imaging patterns associated with prenatal drug exposure.
- The frequency of detectable MRI pathology was similar between exposed and control groups.
Conclusions:
- Cerebral MRI is technically feasible in children with prenatal drug exposure.
- Standard visual analysis of cerebral MRI scans likely offers limited clinical value for assessing these children.
- Further research may be needed to explore advanced neuroimaging techniques for detecting subtle effects.
Abstract:
This study aimed to evaluate cerebral magnetic resonance imaging (MRI) scans of children with prenatal drug exposure in a clinical context. A hospital-based cohort of 10- to 14-year-old children, prenatally exposed to alcohol, opioids, and polysubstances, and a group of sex- and age-matched controls were examined with cerebral MRI. Scans obtained from 34 exposed children and 40 controls were scored based on the presence and degree of pathology by an experienced pediatric neuroradiologist blinded to the participants' background. Overall visual detectable MRI pathology was found in 35% of the exposed children and 33% of the controls (odds ratio = 1.08; 95% confidence interval = 0.36-3.25). No specific imaging pattern following prenatal drug exposure was seen by the means of simple visual analysis of cerebral MRI scans. Although cerebral MRI is feasible, it is probably of limited value in the clinical assessment of children with prenatal drug exposure.
